GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
JAZZ PHARMA INC (JAZZ) [hlAlert]

Rating:
Mkt Perform
JAZZ

JAZZ PHARMA INC (JAZZ) rated Mkt Perform by Bernstein

Posted on: Thursday,  Nov 26, 2015  8:25 AM ET by Bernstein

JAZZ PHARMA INC
(NASDAQ: JAZZ) rated Mkt Perform by Bernstein.

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products to meet unmet medical needs in neurology and psychiatry. The marketed products and late-stage product candidate of the Company include Xyrem (sodium oxybate) oral solution, Luvox CR (fluvoxamine maleate) extended-release capsules and JZP-6 (sodium oxybate). The other product candidates in clinical development are JZP-8 (intranasal clonazepam), being developed for the treatment of recurrent acute repetitive seizures in epilepsy patients who continue to have seizures while on stable anti-epileptic regimens, JZP-4 (sodium and calcium channel antagonist), being developed for the treatment of epilepsy and bipolar disorder, and JZP-7 (ropinirole gel), being developed for the treatment of restless legs syndrome.

A central advantage for Bernstein clients is the ability to harness our highly regarded expertise in investment research and management. Originally known as a value investor, Bernstein has long been known for seeking out stocks with temporarily depressed prices due to unwarranted short-term pessimism about a company’s ability to recover from its current problems. This philosophy is embodied in our flagship Strategic Value portfolio. But since value and growth stocks have alternated leadership—with no clear signal of when one style will give way to the other—we’ve developed a Strategic Growth portfolio that seeks out leading companies whose stock prices don’t fully reflect their companies’ potential for superior earnings growth.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/26/2015 8:25 AM Hold
None
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/25/2015 10:25 AM Hold
None
149.67

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy